Pyros Pharmaceuticals

Today, we honor Juneteenth, a pivotal moment in American history that symbolizes freedom and equality. At Pyros, we stand united in our commitment to foster an inclusive environment. Let's reflect on our progress and recommit to creating a future where justice and opportunity are accessible to all. #Juneteenth #Equality #Inclusion

We are excited to announce the U.S. FDA has approved VIGAFYDE™, the only ready-to-use vigabatrin oral solution.

As we observe Memorial Day, we honor and remember those who have made the ultimate sacrifice in service to our country. We are deeply grateful for their sacrifices and the sacrifices of their families. Today, we reflect on their legacy and pledge to continue our mission of creating a healthier and safer future for all. #MemorialDay #HonorAndRemember #Gratitude #Service #Commitment

As we celebrate National Nurses Week, we want to extend our deepest appreciation to all nurses for their unwavering dedication, compassion, and resilience. Your tireless efforts and selfless care make a profound impact on individuals and communities worldwide. To the exceptional nurses on the Pyros team, your commitment to excellence and patient well-being exemplifies the very best of our organization. hashtag #NursesWeek hashtag #HealthcareHeroes

ADVANCING THE DISCUSSION ON INFANTILE SPASMS Watch an expert panel discussion on delays in diagnosing infantile spasms from the American Epilepsy Society (AES) Annual Meeting. Watch here: https://lnkd.in/e8B5QWPW

Give appropriate patients with infantile spasms a rapid start of treatment. VIGPODER is now available for your patients with infantile spasms. With Quick-Start, treatment can start as fast as 24-48 hours. Qualifying criteria apply. Please see full PI, incl. BOXED WARNING: bit.ly/4atVHEE Learn more: https://lnkd.in/ehFVaAZi

VIGPODER is now available! Eligible patients* get access to a free starter supply up to 30 days of VIGPODER (vigabatrin) treatment as fast as 24-48 hours. *Qualifying criteria apply. Please see full PI, incl. BOXED WARNING: bit.ly/4atVHEE https://lnkd.in/eDEWidUs

Thrilled to share that Pyros Pharmaceuticals has launched VIGPODER™ for the treatment of infantile spasms in appropriate patients! See our attached press release to learn more about this new option in rare disease therapeutics. Please see full PI, including BOXED WARNING, at https://bit.ly/4avpTiX. #PyrosPharma #VIGPODER #PyrosTotalCare #InfantileSpasms #RareDisease

At Pyros, we seek to elevate the standard of care for infantile spasms (IS), providing treatment options that can significantly improve the lives of affected children and their families. We invite you to join us on this journey as we continue to redefine what’s achievable as we shape a brighter future for those affected by IS. Visit https://lnkd.in/ej_3KzYM to request more information from someone on our Sales team. #PyrosPharma #InfantileSpasms

At Pyros, we seek to elevate the standard of care for infantile spasms (IS), providing treatment options that can significantly improve the lives of affected children and their families. We invite you to join us on this journey as we continue to redefine what’s achievable as we shape a brighter future for those affected by IS. Visit https://lnkd.in/evw2Gcx7 to request more information from someone on our Sales team. #PyrosPharma #InfantileSpasms